LivAge is a transcriptomic aging clock that measures biological age in mice using liver RNA data, validated against accelerated-aging models and geroprotective interventions. It provides researchers with a quantifiable method to assess whether experimental treatments actually slow aging-related molecular changes, filling a significant gap in murine aging research.
Key Points
- Transcriptomic clock accurately detects accelerated aging in progeroid mouse models
- Validates established geroprotective interventions reduce molecular age markers
- Accessible online tool enables standardized aging assessment across research labs
Longevity Analysis
The ability to measure transcriptomic age directly addresses a critical bottleneck in translating aging biology into practice: most interventions claimed to slow aging lack objective molecular validation. LivAge quantifies whether genetic modifications or metabolic interventions—caloric restriction, protein restriction, methionine restriction, rapamycin—actually alter the underlying gene expression patterns that correlate with aging and disease risk. This creates a bridge between animal research and human application, allowing researchers to distinguish interventions that produce genuine changes in age-related biology from those that merely affect surface markers. For practitioners evaluating longevity strategies, this validates which approaches have molecular evidence for slowing aging rather than speculation.
Original published by Wiley Aging Cell, by Víctor Celemín‐Capaldi, Guillermina Bea, David Roiz‐Valle, Alejandro P. Ugalde, Clea Bárcena, Pedro M. Quirós, José M. P. Freije .